Cargando…
Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
BACKGROUND: Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Metabolomics may help refine risk assessment and potentially guide HF management, but dedicated studies are few. This study aims at stratifying the long-term risk of death in a cohort of patients affected by HF d...
Autores principales: | Vignoli, Alessia, Fornaro, Alessandra, Tenori, Leonardo, Castelli, Gabriele, Cecconi, Elisabetta, Olivotto, Iacopo, Marchionni, Niccolò, Alterini, Brunetto, Luchinat, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021397/ https://www.ncbi.nlm.nih.gov/pubmed/35463749 http://dx.doi.org/10.3389/fcvm.2022.851905 |
Ejemplares similares
-
Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020) -
High‐Throughput Metabolomics by 1D NMR
por: Vignoli, Alessia, et al.
Publicado: (2018) -
Differential Network
Analysis Reveals Molecular Determinants
Associated with Blood Pressure and Heart Rate in Healthy Subjects
por: Vignoli, Alessia, et al.
Publicado: (2020) -
NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort
por: Vignoli, Alessia, et al.
Publicado: (2019) -
Cerebral lesions in hematological malignancies: a case report
por: D’Ettore, Nicoletta, et al.
Publicado: (2021)